Thus, the reduced MMP2 activity may contribute to the decrease of migration and invasion caused by pioglitazone, rosiglitazone and WY‐14643 in the glioblastoma cells under in vitro and in vivo conditions. This evidence concerns the gene MMP2 and glioblastoma.